Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 4/2022

10.08.2021 | Original Article

Kisspeptin levels in relation to sex hormone profile among PCOS patients

verfasst von: Elham Zarei, Maryam Moradi Binabaj, Fatemeh Mohammad Zadeh, Sepideh Bakhshandeh Nosrat, Gholamreza Veghari, Azadreza Mansourian

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Polycystic ovary syndrome (PCOS) is a common endocrine disease among women in the reproductive age that is associated with consequences such as insulin resistance and hyperandrogenemia. This study was aimed to assess the association of sex hormone profile and kisspeptin levels in PCOS women in Gorgan, Iran.

Methods

In this case-control study, 43 women with diagnosed PCOS between the ages of 15 and 37 years and 40 healthy demographically matched controls were recruited. Sex hormone profile and kisspeptin levels were measured in these subjects using ELISA assay kits.

Results

Follicle stimulating hormone (FSH), sex hormone binding globulin (SHBG), and kisspeptin levels were significantly lower in cases than in controls. Luteinizing hormone (LH), free-testosterone (FT), 17-OH-progesterone (17-OH-P), dehydroepiandrosterone sulfate (DHEA-S), estradiol (E2), and free androgen index (FAI) were higher in PCOS significantly. There was a significant positive correlation between kisspeptin levels and LH and E2 in cases (p = 0.037 and p = 0.024, respectively). The results of the regression analysis have shown a significant association between the LH and kisspeptin concentrations in PCOS group (r = 0.275, p = 0.037).

Conclusion

PCOS patients had lower plasma kisspeptin level that was positively correlated with LH and estradiol levels. Also, higher levels of free androgens were demonstrated in these patients. It is suggested that kisspeptin may be involved in complex interactions of the sex hormone endocrine system of PCOS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Emekci Ozay O, Ozay AC, Acar B et al (2016) Role of kisspeptin in polycystic ovary syndrome (PCOS). Gynecol Endocrin 32(9):718-722 Emekci Ozay O, Ozay AC, Acar B et al (2016) Role of kisspeptin in polycystic ovary syndrome (PCOS). Gynecol Endocrin 32(9):718-722
2.
Zurück zum Zitat Anwar AA, Abdullah N, Padjalangi AN et al (2021) Serum leptin concentration is correlated to insulin resistance in polycystic ovary syndrome (PCOS) patients. Mole Cell Biomed Sci 5(2):93–7CrossRef Anwar AA, Abdullah N, Padjalangi AN et al (2021) Serum leptin concentration is correlated to insulin resistance in polycystic ovary syndrome (PCOS) patients. Mole Cell Biomed Sci 5(2):93–7CrossRef
3.
Zurück zum Zitat Zeng X, Xie Y-J, Liu Y-T et al (2020) Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clinica Chimica Acta 502:214–221CrossRef Zeng X, Xie Y-J, Liu Y-T et al (2020) Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clinica Chimica Acta 502:214–221CrossRef
4.
Zurück zum Zitat Witchel SF, Tena-Sempere M (2013) The Kiss1 system and polycystic ovary syndrome: lessons from physiology and putative pathophysiologic implications. Fertility and sterility 100(1):12–22CrossRef Witchel SF, Tena-Sempere M (2013) The Kiss1 system and polycystic ovary syndrome: lessons from physiology and putative pathophysiologic implications. Fertility and sterility 100(1):12–22CrossRef
5.
Zurück zum Zitat Farrell K, Antoni MH (2010) Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertility and sterility 94(5):1565–1574CrossRef Farrell K, Antoni MH (2010) Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertility and sterility 94(5):1565–1574CrossRef
6.
Zurück zum Zitat Yilmaz S, Kerimoglu OS, Pekin A et al (2014) Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Bio 180:56–60CrossRef Yilmaz S, Kerimoglu OS, Pekin A et al (2014) Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Bio 180:56–60CrossRef
7.
Zurück zum Zitat Keen KL, Wegner FH, Bloom SR et al (2008) An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology 149(8):4151–4157CrossRef Keen KL, Wegner FH, Bloom SR et al (2008) An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology 149(8):4151–4157CrossRef
8.
Zurück zum Zitat Julie-Ann PQ, Li RP, Millar et al (2013) Kisspeptin signaling is required for the luteinizing hormone response in anestrous ewes following the introduction of males. PLoS One 8(2):e57972 Julie-Ann PQ, Li RP, Millar et al (2013) Kisspeptin signaling is required for the luteinizing hormone response in anestrous ewes following the introduction of males. PLoS One 8(2):e57972
9.
Zurück zum Zitat Dhillo WS, Chaudhri OB, Patterson M et al (2005) Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrin Metab 90(12):6609–6615CrossRef Dhillo WS, Chaudhri OB, Patterson M et al (2005) Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrin Metab 90(12):6609–6615CrossRef
10.
Zurück zum Zitat Yerlikaya E, Akin F, Turgut S et al (2013) Plasma kisspeptin levels in polycystic ovary syndrome. in 15th Eu Cong Endocrin. BioScientifica Yerlikaya E, Akin F, Turgut S et al (2013) Plasma kisspeptin levels in polycystic ovary syndrome. in 15th Eu Cong Endocrin. BioScientifica
11.
Zurück zum Zitat Jeon YE, Lee KE, Jung JA et al (2013) Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest 75(4):268–274CrossRef Jeon YE, Lee KE, Jung JA et al (2013) Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest 75(4):268–274CrossRef
12.
Zurück zum Zitat Chen X, Mo Y, Li L et al (2010) Increased plasma metastin levels in adolescent women with polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol 149(1):72–76CrossRef Chen X, Mo Y, Li L et al (2010) Increased plasma metastin levels in adolescent women with polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol 149(1):72–76CrossRef
13.
Zurück zum Zitat Gorkem U, Togrul C, Arslan E et al (2018) Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gynecol Endocrin 34(2):157–160CrossRef Gorkem U, Togrul C, Arslan E et al (2018) Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gynecol Endocrin 34(2):157–160CrossRef
14.
Zurück zum Zitat Yerlikaya E, Akin F, Turgut S et al (2013) Plasma kisspeptin levels in polycystic ovary syndrome. in Endocrine Abstracts. Bioscientifica Yerlikaya E, Akin F, Turgut S et al (2013) Plasma kisspeptin levels in polycystic ovary syndrome. in Endocrine Abstracts. Bioscientifica
15.
Zurück zum Zitat Panidis D, Rousso D, Koliakos G et al (2006) Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertility and sterility 85(6):1778–1783CrossRef Panidis D, Rousso D, Koliakos G et al (2006) Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertility and sterility 85(6):1778–1783CrossRef
16.
Zurück zum Zitat Oakley AE, Clifton DK, Steiner RA (2009) Kisspeptin signaling in the brain. Endocrine Rev 30(6):713–743CrossRef Oakley AE, Clifton DK, Steiner RA (2009) Kisspeptin signaling in the brain. Endocrine Rev 30(6):713–743CrossRef
17.
Zurück zum Zitat Richard N, Corvaisier S, Camacho E et al (2009) KiSS-1 and GPR54 at the pituitary level: overview and recent insights. Peptides 30(1):123–129CrossRef Richard N, Corvaisier S, Camacho E et al (2009) KiSS-1 and GPR54 at the pituitary level: overview and recent insights. Peptides 30(1):123–129CrossRef
18.
Zurück zum Zitat Hamamura H, Adachi H, Enomoto M et al (2020) Serum proprotein convertase subtilisin/kexin type 9 (PCSK9) is independently associated with insulin resistance, triglycerides, lipoprotein (a) levels but not low-density lipoprotein cholesterol levels in a general population. J Atheros Throm 56390 Hamamura H, Adachi H, Enomoto M et al (2020) Serum proprotein convertase subtilisin/kexin type 9 (PCSK9) is independently associated with insulin resistance, triglycerides, lipoprotein (a) levels but not low-density lipoprotein cholesterol levels in a general population. J Atheros Throm 56390
19.
Zurück zum Zitat E-Shehawy YM, Safan MA (2015) Evaluation of serum anti-mullerian hormone (amh) and plasma metastin levels in women with polycystic ovary syndrome (PCOS) E-Shehawy YM, Safan MA (2015) Evaluation of serum anti-mullerian hormone (amh) and plasma metastin levels in women with polycystic ovary syndrome (PCOS)
20.
Zurück zum Zitat Nyagolova PV, Mitkov MD, Orbetzova MM et al (2016) Kisspeptin and galanin-like peptide (GALP) levels in women with polycystic ovary syndrome Nyagolova PV, Mitkov MD, Orbetzova MM et al (2016) Kisspeptin and galanin-like peptide (GALP) levels in women with polycystic ovary syndrome
21.
Zurück zum Zitat Colledge WH (2004) GPR54 and puberty. Trends in Endocrin Meta. 15(9):448–453CrossRef Colledge WH (2004) GPR54 and puberty. Trends in Endocrin Meta. 15(9):448–453CrossRef
22.
Zurück zum Zitat Brown RE, Wilkinson DA, Imran SA et al (2012) Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS). Brain research 1467:1–9CrossRef Brown RE, Wilkinson DA, Imran SA et al (2012) Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS). Brain research 1467:1–9CrossRef
23.
Zurück zum Zitat Iwasa T, Matsuzaki T, Yano K et al (2018) The effects of chronic testosterone administration on hypothalamic gonadotropin-releasing hormone regulatory factors (Kiss1, NKB, pDyn and RFRP) and their receptors in female rats. Gynecol Endocrin 34(5):437–441CrossRef Iwasa T, Matsuzaki T, Yano K et al (2018) The effects of chronic testosterone administration on hypothalamic gonadotropin-releasing hormone regulatory factors (Kiss1, NKB, pDyn and RFRP) and their receptors in female rats. Gynecol Endocrin 34(5):437–441CrossRef
24.
Zurück zum Zitat Iwasa T, Matsuzaki T, Yano K et al (2018) Effects of dihydrotestosterone administration on the expression of reproductive and body weight regulatory factors in ovariectomized and estradiol-treated female rats. Gynecol Endocrin 34(1):73–77CrossRef Iwasa T, Matsuzaki T, Yano K et al (2018) Effects of dihydrotestosterone administration on the expression of reproductive and body weight regulatory factors in ovariectomized and estradiol-treated female rats. Gynecol Endocrin 34(1):73–77CrossRef
25.
Zurück zum Zitat Suresh S, Vijayakumar T (2015) Correlations of insulin resistance and serum testosterone levels with LH: FSH ratio and oxidative stress in women with functional ovarian hyperandrogenism. Ind J Clin Biochem 30(3):345–350CrossRef Suresh S, Vijayakumar T (2015) Correlations of insulin resistance and serum testosterone levels with LH: FSH ratio and oxidative stress in women with functional ovarian hyperandrogenism. Ind J Clin Biochem 30(3):345–350CrossRef
26.
Zurück zum Zitat Katulski K, Podfigurna A, Czyzyk A et al (2018) Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine 1-9 Katulski K, Podfigurna A, Czyzyk A et al (2018) Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine 1-9
27.
Zurück zum Zitat Willis D, Mason H, Gilling-Smith C et al (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrin Meta 81(1):302-309 Willis D, Mason H, Gilling-Smith C et al (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrin Meta 81(1):302-309
Metadaten
Titel
Kisspeptin levels in relation to sex hormone profile among PCOS patients
verfasst von
Elham Zarei
Maryam Moradi Binabaj
Fatemeh Mohammad Zadeh
Sepideh Bakhshandeh Nosrat
Gholamreza Veghari
Azadreza Mansourian
Publikationsdatum
10.08.2021
Verlag
Springer International Publishing
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 4/2022
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-021-02733-w

Weitere Artikel der Ausgabe 4/2022

Irish Journal of Medical Science (1971 -) 4/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.